|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from other financial institutions | ||||||||||||||||||||
| Interest-bearing deposits in other financial institutions | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Interest-bearing time deposits in other financial institutions | ||||||||||||||||||||
| Loans receivable, net of allowance for loan losses: December 31, 2022, $8,129 and December 31, 2021, $6,715 | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses: March 31, 2025, $7,279 and December 31, 2024, $7,571 | ||||||||||||||||||||
| Securities, at fair value | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses: September 30, 2025, $8,814 and December 31, 2024, $7,571 | ||||||||||||||||||||
| Foreclosed assets, net | ||||||||||||||||||||
| Stock in Federal Home Loan Bank ("FHLB") and Federal Reserve Bank ("FRB"), at cost | ||||||||||||||||||||
| Premises held-for-sale | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Deferred taxes | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Subordinated notes, net of unamortized issuance costs | ||||||||||||||||||||
| Advance payments by borrowers for taxes and insurance | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 25,000,000 shares authorized, none issued or outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, 100,000,000 shares authorized; 12,460,678 shares issued at September 30, 2025 and December 31, 2024 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
